Shelley Hwang has just received a copy of the book Adverse Reactions to Biologics that includes her chapter on the monoclonal antibodies used in Melanoma patients: ipilimumab, nivolumab and pembrolizumab. Shelley is one of the CTSR experts in the cutaneous effects of checkpoint inhibitors used in patients with cancers.
Adverse Reactions to Biologics
Last Updated on 6 December 2017 by Prof Fernandez-Peñas